Progressive MS: Neuroinflammation, NF-kB and the Unexpected Role of Ginger

Progressive multiple sclerosis — whether primary (MS-PP) or secondary (MS-SP) — is the most debilitating and least treatable form of MS. Unlike the relapsing-remitting form, traditional disease-modifying treatments have only limited effectiveness on progressive forms, which are dominated by chronic neurodegeneration rather than by acute inflammatory outbreaks.

Mechanisms of Progressive MS: NF-kB and Microglia

In progressive MS, the driving force behind the disease is not selfginger-2026">peripheral immunity (T lymphocytes in the blood) but intrinsic neuroinflammation of the CNS:

• Chronically activated microglia: microglia (resident macrophages of the brain) are activated by myelin debris and produce TNF-α, IL-1β, NO and free radicals via NF-kB
• Reactive astrocytes: transformed into pro-inflammatory A1 phenotype under the influence of NF-kB → neurotoxicity
• cortisol-natural">ginger mitochondrial oxidative stress: neurons in chronic lesions accumulate mitochondrial damage → energy deficit → axonal apoptosis
• Failure of remyelination: precursor oligodendrocytes cannot mature due to the NF-kB-dependent inflammatory environment

Gingerol and Neuroinflammation: Promising Preliminary Data

Several in vitro and in vivo studies show that the active compounds of ginger partially cross the blood-brain barrier (BBB) and exert effects neuroprotectors:

• Inhibition of NF-kB microglia: 6-gingerol reduces microglial activation and TNF-α production by 45% in models of neuroinflammation (Neurochemistry International, 2019)
• Protection of oligodendrocytes: gingerol protects oligodendrocytes from oxidative stress in EAE models (experimental autoimmune encephalomyelitis, the animal model of MS) (Multiple Sclerosis Journal, 2020)
• Activation of Nrf2: induces the production of glutathione and superoxide dismutase in astrocytes and neurons → reduction of mitochondrial oxidative stress
• Effects on the BBB: gingerol reduces the permeability of the BBB by inhibiting MMPs (matrix metalloproteinases) induced by NF-kB

Important Limitations to Specify

It's crucial to be honest: progressive MS is an extremely complex disease and this data, while promising, is primarily preclinical. Gingerol is not a treatment for MS. Patients taking natalizumab, ocrelizumab, siponimod or other DMTs should not change their treatment without neurological advice. INTI can be considered as a complement anti-inflammatory ginger general, not like alternative therapeutic.

INTI in the Progressive MS Context

For progressive MS patients seeking documented complementary approaches:

• Mediterranean diet rich in polyphenols (oleocanthal, resveratrol, gingerol) → reduction of neuroinflammation
• INTI 15ml/day: gingerol intake sugar free in excess (sugar activates NF-kB and aggravates neuroinflammation)
• Vitamin D (2000-4000 IU/day depending on serum level): essential in MS
• Adapted aerobic physical activity: demonstrated to reduce activated microglia

Conclusion

Progressive MS is dominated by chronic neuroinflammation via NF-kB and microglia—a target on which gingerol has documented, albeit preliminary, effects. INTI, sugar-free and artisanal preparation, is the cleanest carrier of gingerol available. A reasoned complement – ​​not a treatment – ​​in the integrative management of progressive MS.

Informational article only. MS absolutely requires specialized neurological monitoring and appropriate basic treatment.